Differential Inducing Effect of Benzo[a]pyrene on Gene Expression and Enzyme Activity of Cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar Rats

被引:23
作者
Floreani, Maura [1 ]
Gabbia, Daniela [1 ]
Barbierato, Massimo [1 ]
De Martin, Sara [1 ]
Palatini, Pietro [1 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy
关键词
CYP1A1; CYP1A2; benzo[a]pyrene induction; Sprague-Dawley rats; Wistar rats; ARYL-HYDROCARBON RECEPTOR; LIVER-MICROSOMES; SUBSTRATE-SPECIFICITY; STRAIN DIFFERENCES; INDUCTION; INDUCIBILITY; LANSOPRAZOLE; OMEPRAZOLE; INDUCERS; CYP1A1;
D O I
10.2133/dmpk.DMPK-12-RG-035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to compare RT-PCR, Western blot and determination of enzyme activity in the assessment of the induction of cytochromes P450 (CYPs) 1A1 and 1A2 by benzo[a]pyrene (BaP) in Sprague-Dawley and Wistar rats. Inhibition studies and kinetic analyses confirmed literature data indicating that methoxyresorufin is a specific CYP1A2 substrate in both uninduced and BaP-treated rats, whereas ethoxyresorufin is a specific CYP1A1 substrate only in BaP-treated rats. BaP treatment increased mRNA and protein expressions of both CYP1A enzymes to a greater extent in Wistar than Sprague-Dawley rats. It consistently caused a higher increase in mRNA and protein expression of the aryl hydrocarbon receptor in the former rats. By contrast, CYP1A2 enzyme activity was much more markedly increased in Sprague-Dawley than Wistar rats and CYP1A1 activity was induced to similar levels. A BaP-induced increase in the turnover number of CYP1A enzymes in Sprague-Dawley rats, relative to Wistar rats, may provide a plausible explanation for the differential effect of BaP on gene expression and enzyme activity. These results have methodological implications, since they show that RT-PCR and Western blot may not provide a quantitative measure of induction of CYP1A activity, which is the actual measure of the change in CYP1A-mediated metabolism.
引用
收藏
页码:640 / 652
页数:13
相关论文
共 40 条
[1]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[2]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[3]   Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR [J].
Caron, E ;
Rioux, N ;
Nicolas, O ;
Lebel-Talbot, H ;
Hamelin, BA .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2005, 19 (06) :368-378
[4]  
CONNEY AH, 1982, CANCER RES, V42, P4875
[5]  
Copeland RA, 2000, ENZYMES PRACTICAL IN
[6]  
CURIPEDROSA R, 1994, J PHARMACOL EXP THER, V269, P384
[7]   Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor [J].
Denison, Michael S. ;
Soshilov, Anatoly A. ;
He, Guochun ;
DeGroot, Danica E. ;
Zhao, Bin .
TOXICOLOGICAL SCIENCES, 2011, 124 (01) :1-22
[8]   Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline [J].
Dilger, K ;
Zheng, ZC ;
Klotz, U .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) :438-444
[9]   Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes [J].
Eagling, VA ;
Tjia, JF ;
Back, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) :107-114
[10]   Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver [J].
Elovaara, Eivor ;
Mikkola, Jouni ;
Stockmann-Juvala, Helene ;
Luukkanen, Leena ;
Keski-Hynnila, Helena ;
Kostiainen, Risto ;
Pasanen, Markku ;
Pelkonen, Olavi ;
Vainio, Harri .
ARCHIVES OF TOXICOLOGY, 2007, 81 (03) :169-182